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Theophylline controlled release matrix tablets were prepared with guar gum in two ratios and with 
three different hardness of 5, 6 and 7kg/cm2. Theophylline controlled release granules were prepared 
and evaluated for the angle of repose, bulk density, tapped density, compressibility index and hausners 
ratio. All the formulation showed good flow properties. The compressed tablets were evaluated for the 
hardness, uniformity of weight, friability, drug content and invitro dissolution studies. All the 
formulations showed compliance with pharmacopial standards. There was no interaction between 
drug, polymer and other excipients. It was confirmed by FTIR studies. Among all the formulations F6 
(i.e. polymer ratio1:2 and hardness 7kg/cm2) showed prolong release when compare to other 
formulations. The drug release kinetics showed zero order. The optimum formulation (F6) was stable 
when it was stored at 40 + 20 C, 280 + 20 C and at 450 + 20 C for 6 months.  
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INTRODUCTION 
Controlled release products are designed to maintain constant therapeutic plasma concentration of the 
drug within the therapeutic range of the drug over prolonged periods1. Matrix is defined as a well-
mixed composite of one or more drugs with gelling agent i.e. hydrophilic polymers2. Matrix 
technologies have often proven popular among the oral controlled drug delivery technologies because 
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of their simplicity, ease in manufacturing, high level of reproducibility, stability of the raw materials 
and dosage form and ease of scale-up and process validation3. Theophylline is a methylxanthine 
derivative and it is very effective in the chronic treatment of bronchial asthma and bronchospastic 
reaction. Its therapeutic concentration range is narrow from 10 to 20 g/ml while toxicity usually 
appears at concentration above 20 g/ml4. Since theophylline having narrow therapeutic index it can 
be used as a controlled release product so as to protect asthma patients from frequent attacks and to 
prevent from toxic side effects5. The main aim of the study was to formulate therapeutic controlled 
release tablets using natural polymer like guar gum with two different ratios (1:1 and 1:2) and also 
varying the hardness of the tablets (5, 6 and 7 kg/cm2 respectively). 
Materials  
 
Theophylline was procured from (Amratlal and co. Chennai). Guar gum and magnesium stearate were 
obtained from (Loba chemi. Pvt; Ltd, Mumbai). Lactose monohydrate was received from (Paxmy 
speciality chemi. Chennai). Polyvinyl pyrolidone and isoprophyl alcohol were obtained from (S.d.fine-
chem.Pvt; Ltd, Mumbai). All other chemicals used were of analytical grade. 
Methods 
Preparation of controlled release matrix tablets  
Table 1. Composition of Theophylline CR matrix tablets (mg/tablet) 
Ingredients  (mg) 
Theophylline: Guar 
Gum  (1:1) 
Theophylline: Guar Gum  
(1:2) 
Theophylline 100 100 
Guar gum 100 200 
Lactose monohydrate 296 196 
Polyvinyl pyrolidone K30 (PVP K30) 2 2 
Magnesium stearate 2 2 
Iso propyl alcohol (IPA) q.s q.s 
(1:1) and (1:2) are drug : polymer ratio 
Matrix tablets were prepared by wet granulation technique. Theophylline controlled release tablets 
were prepared with guar gum and other additives that are listed in the table-1. Theophylline, guar gum 
and lactose were mixed together. Isopropyl alcohol in which PVP K-30 was previously dissolved was 
added to the above powder mixture and mixed well to form a coherent mass. Then the coherent mass 
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was passed through sieve no-16 and the granules were dried at 40° + 2°C for 2 hours. Dried granules 
were passed through sieve no-20. After the granules were evaluated, magnesium stearate was added to 
the granules. Then the lubricated granules were compressed into tablets weighing 500mg using 12mm 
round flat faced punches in a rotary tablet press (Rimek mini press-1, Model RSB-4, Karnavathi 
Engineering, Ahmedabad) to a hardness of 5, 6 and 7 kg/cm2. The compressed tablets were dedusted 
and evaluated for various tablet properties. 
Evaluation of granules  
The granules were evaluated for angle of repose6,7, bulk density8, tapped density8, compressibility 
index and hausner ratio9 for micromeritic properties.  
Evaluation of tablets 
To design tablets and tablet production quality test, the formulated tablets were evaluated for thickness 
and diameter (using a vernier caliper), hardness test (using Monsanto hardness tester)10 and friability 
(using Roche friabilator)11. For weight variation test12, 20 tablets of each formulation were selected at 
random and weighed individually. The individual weights were compared with average weight for 
determination of weight variation. The results were expressed in table-3. For content uniformity test13, 
ten tablets were powdered in a mortar. The powder equivalent to 100mg of theophylline was weighed 
and transferred to 100ml volumetric flask. It was dissolved in pH 7.4. From this appropriate dilution 
were made and the absorbance was analyzed at 277nm using UV double beam spectrophotometer. 
FT-IR studies 
It was used to study the interactions between the drug and polymer. The drug and polymer must be 
compatible with one another to produce a stable product. Drug and polymer interactions were studied 
by using FTIR (Shimadzu, Japan model – 8400S) as per the method described by Pathra et.al14. IR 
spectral analysis of pure theophylline, guar gum and theophylline with guar gum (1:2) were carried 
out. The peak and patterns produced by the pure drug were compared with combination of pure drug 
and polymer.  
In-vitro release studies 
In-vitro drug release study was carried out using disso 2000 apparatus (basket type). Dissolution 
medium 900 ml of pH 7.4 was placed into the dissolution flask maintaining the temperature at 37oC + 
0.5oC and rpm of 50 for 10hrs. Samples measuring 10ml were with drawn every 30min intervals, 
replace same quantity of fresh dissolution medium. Collected samples were suitably diluted with pH 
7.4 and analyzed at 277 nm using pH 7.4 as blank in UV-double beam spectrophotometer. 
Drug release kinetics 
To analyze the mechanism of drug release rate kinetics, the results of invitro release profile were 
plotted in various kinetic models like zero order, first order, higuchi model and korsmeyer – peppas15.  
Stability studies 
The optimised formulation F6 was taken for the stability study. The tablets were packed in amber-
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colored bottle and kept at 40 + 20 C, 280 + 20 C (RH 60 + 5%) and 450 + 20 C (RH 75 + 5%) for a period 
of 6 months. The tablets were observed physically for any colour change. Tablets were taken at 2, 4 
and 6th months intervals and evaluated for drug content and invitro release study2. 
Results and Discussion 
The granules of all the formulations were evaluated for angle of repose, bulk density, tapped density, 
and compressibility index and hausner ratio. The angle of repose was found to be 31o02’ + 0.66 – 
32o55’ + 0.69. It indicates that granules have a good flow property. The bulk density and tapped 
density was found to be in the range of 0.3538 + 0.00 - 0.3947 + 0.01 gm/cc and 0.3990 + 0.01 - 
0.4439 + 0.01 gm/cc respectively. The compressibility and hausner ratio was found to be 9.89 +1.66 to 
14.21 + 1.27 and 1.11 + 0.02 to 1.17 + 0.02 indicating good flow character of the granules (table-2). 
All the results are within the prescribed limits10. 
Table 2. Evaluation of theophylline matrix granules  
Theophylline : Guar Gum 
5 kg/cm2 6 kg/cm2 7 kg/cm2
Parameters*
1 : 1 
(F-1) 
1 : 2 
(F-2) 
1 : 1 
(F-3) 
1 : 2 
(F-4) 
1 : 1 
(F-5) 
1 : 2 
(F-6) 




































































* All values are expressed as mean + SD, n=5 
The hardness of the tablets for all the formulations was in the range of 5-7 kg/cm2. The uniformity 
weight of 20 tablets of all the formulations was within 5% deviation. The friability of all the 
formulation was less than 1%. Drug content of all the formulations were found to be in the range of 96 
to 99 % (table-3). All the results are within the prescribed limits10. 
The FT-IR studies showed that N-H stretching, C-H stretching, C-O stretching, C-H bending, O-H 
deformation, C-H out of plane bending of pure theophylline and theophylline with guar gum (1:2 
ratio) were almost in the same region of wave number ranging from 3529 cm-1 to 609.53 cm-1. It 
showed that there was no significant interaction between the drug and polymer and they are 
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compatible with each other.  
Table 3. Evaluation of theophylline controlled release matrix tablets 
Theophylline : Guar gum  
5 Kg/Cm2 6 Kg/Cm2 7 Kg/Cm2
Parameters*
1 : 1 
(F-1) 
1 : 2 
(F-2) 
1 : 1 
(F-3) 
1 : 2 
(F-4) 
1 : 1 
(F-5) 










6.02 +  
0.16 
7.03 +  
0.34 
7.01 +  
0.25 
Uniformity of 




















0.28 +  
0.04 
0.15 +  
0.07 










97.4 +  
0.24 
96.6 +  
0.28 
98.8 +  
0.38 







4.2 + 0.00 4.1 + 0.03 4.1 + 0.02 













* All values are expressed as mean + SD, n=5 
The results of the invitro release study for all the formulations are shown in figure-1.  
At the end of 10th hours the cumulative percentage drug release for the formulations F1-F6 was found 
to be 97.2 + 0.77; 88.2 + 0.96; 85.5 + 1.25; 82.8 + 0.49; 79.2 + 0.77 and 75.6 + 1.66 respectively. 
Among the six formulations, F6 showed prolonged drug release. An increase in the compression force 
increases the hardness and the apparent density of the tablet, thereby reducing the matrix porosity in 
the tablet. The release rate decreases with increase in compression force16. The drug release was found 
to be faster at lower compression force than at higher ones because of the relatively larger matrix 
porosity of the tablet, which allowed greater penetration of dissolution fluid into the matrix, thus 
enhancing polymer disentanglement and drug dissolution17. The controlled drug release may also be 
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Figure 1. Comparison of invitro drug release study of theophylline controlled release formulations F-1 

































The release rate kinetic data for all formulations is shown in table-4. When the data were plotted 
according to zero order, the formulations showed a high linearity with regression co-efficient values 
(R2) between 0.9748 – 0.9895. It showed that the drug release follows zero order19. Diffusion is related 
to transport of drug from the matrix tablets into the dissolution medium depends upon the 
concentration. This is explained by Higuchi’s equation. When the data were plotted according to 
Higuchi’s equations, the regression co-efficient values (R2) were between 0.9630 – 0.9879.By using 
korsmeyer model, the mechanism of drug release was determined. If n = < 0.45, it is fickian diffusion 
and if n= 0.45 – 0.89, it is non-fickian diffusion transport19. The results of all the formulations showed 
that the n values are between 0.6739 – 0.6901. It proved that all formulations followed non-fickian 
transport mechanism19 both diffusion and erosion20. 
Stability study for the optimized formulation F-6 showed that there was no significant colour change 
in all the tablets after 6 months. Drug content was estimated and invitro drug release was carried out 
after 2, 4 and 6 months. The percentage of drug content was between 96.8 to 98.8% upto 6 months 
(table-5) in all the three temperatures. Dissolution studies showed that there was no much deviation in 
the percentage of drug release (figure-2,3and4). It showed that F-6 formulation was stable at different 
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Table 4. Drug release kinetics of theophylline controlled release matrix tablet formulations 
Correlation Co-efficient (r2) value Korsmeyers - Peppas 
Formulation 
Code 





efficient (r2) value 
F-1 0.9854 0.8523 0.9683 0.9423 0.6846 0.9901 
F-2 0.9846 0.9552 0.9789 0.9853 0.6816 0.9958 
F-3 0.9748 0.9760 0.9879 0.9919 0.6739 0.9938 
F-4 0.9889 0.9693 0.9739 0.9892 0.6802 0.9984 
F-5 0.9831 0.9851 0.9808 0.9952 0.6784 0.9985 
F-6 0.9895 0.9698 0.9630 0.9855 0.6901 0.9910 
Table 5. Stability study for the optimized formulation  F-6 drug content estimation 
Percentage drug content  Time in months 
40 + 20 C 270 + 20 C 450 + 20 C 
0 day 98.8 + 0.38 98.8 + 0.38 98.8 + 0.38 
2 98.8 + 0.60 98.8 + 0.83 97.6 + 0.41 
4 97.6 + 0.33 97.6 + 0.76 97.4 + 0.29 
6 97.4 + 0.51 97.0 + 0.93 96.8 + 0.22 
* All values are expressed as mean + SD, n=5 



































Ars Pharm, Vol. 50 nº4; 205-214 
RAJA SEKHARAN T. Formulation and Evaluation of Theophylline Controlled… 212 








































































Results of the present study confirmed that the polymer ratio and hardness plays a major role in drug 
release. As the polymer ratio and hardness of the tablets increased the drug release was prolonged. 
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